Methods and compositions for treating or preventing peripheral neuropathies
    3.
    发明授权
    Methods and compositions for treating or preventing peripheral neuropathies 失效
    用于治疗或预防周围神经病变的方法和组合物

    公开(公告)号:US06884770B1

    公开(公告)日:2005-04-26

    申请号:US09569386

    申请日:2000-05-11

    摘要: The present application is directed to the discovery that hedgehog gene products are able to protect peripheral nerve cells under conditions which otherwise result in peripheral neuropathy. Certain aspects of the invention are directed to preparations of hedgehog polypeptides, or other molecules which regulate patched or smoothened signalling, and their uses as protective agents against both acquired and hereditary neuropathies. As used herein, “peripheral neuropathy” refers to a disorder affecting a segment of the peripheral nervous system. For instance, the method of the present invention can be used as part of a treatment program in the management of neuropathies associated with systemic disease, e.g., viral infections, diabetes, inflamation; as well as genetically acquired (hereditary) neuropathies, e.g., Charcot-Marie-Tooth disease; and neuropathies caused by a toxic agent, e.g., a chemotherapeutic agent such as vincristine.

    摘要翻译: 本申请旨在发现刺猬蛋白基因产物能够在否则导致周围神经病变的条件下保护外周神经细胞。 本发明的某些方面涉及刺猬蛋白多肽或调节修补或平滑信号传导的其它分子及其作为对获得性和遗传性神经病的保护剂的用途的制备。 如本文所用,“周围神经病”是指影响周围神经系统的一部分的病症。 例如,本发明的方法可用作治疗与全身疾病相关的神经病的治疗方案的一部分,例如病毒感染,糖尿病,炎症; 以及遗传获得(遗传性)神经病,例如Charcot-Marie-Tooth疾病; 以及由毒性剂例如长春新碱等化学治疗剂引起的神经病变。

    Motilin-like polypeptides with gastrointestinal motor stimulating
activity
    5.
    发明授权
    Motilin-like polypeptides with gastrointestinal motor stimulating activity 失效
    胃肠道运动刺激活性的胃动素样多肽

    公开(公告)号:US5422341A

    公开(公告)日:1995-06-06

    申请号:US103490

    申请日:1993-08-06

    CPC分类号: C07K14/63 A61K38/00

    摘要: This invention pertains to polypeptides, other than motilin, having gastrointestinal motor stimulating activity and represented by the formula: ##STR1## wherein A and D are lipophilic aliphatic or alicyclic amino acids; B is L-proline or L-alanine; E is an aromatic, lipophilic aliphatic, or alicyclic amino acid; F is an aromatic or heteroaromatic amino acid; G is glycine or D-alanine; H is L-glutamic acid or L-glutamine; I is L-glutamine, L-glutamic acid, or L-alanine; J is a direct bond or is selected from, inter alia Z, Z-Leu, Z-Leu-Gln, Z-Leu-Gln-Glu (SEQ ID NO:2) or Z-Leu-Gln-Glu-Lys (SEQ ID NO:3), wherein Z is, inter alia, arginine, D-arginine, D-homoarginine, or D-lysine, and further wherein the amino acids represented by A, D, E and F are L-stereoisomers; R.sub.1 is lower-alkyl or allyl; R.sub.2 is hydrogen, lower-alkyl, propargyl, or allyl; R.sub.3 is hydrogen, lower-alkyl, and allyl; R.sub.4 is lower-alkyl, cycloalkyl, heteroaryl, unsubstituted aryl, and aryl substituted by halogen, hydroxy, or lower-alkoxy; R.sub.5 is --CH.sub.2 CONH.sub.2, aminoalkyl, or guanidinoalkyl; R.sub.6 is --COOH or --CONH.sub.2 ; and m is 0 or 1, and the asymmetric carbon represented by * may be D or L configuration, with certain specified provisos.

    摘要翻译: 本发明涉及具有胃肠运动刺激活性并由下式表示的除胃动素以外的多肽:其中A和D是亲脂性脂族或脂环族氨基酸; B是L-脯氨酸或L-丙氨酸; E是芳族,亲脂性脂族或脂环族氨基酸; F是芳族或杂芳族氨基酸; G是甘氨酸或D-丙氨酸; H是L-谷氨酸或L-谷氨酰胺; 我是L-谷氨酰胺,L-谷氨酸或L-丙氨酸; J是直接键或选自Z,Z-Leu,Z-Leu-Gln,Z-Leu-Gln-Glu(SEQ ID NO:2)或Z-Leu-Gln-Glu-Lys(SEQ 其中Z特别是精氨酸,D-精氨酸,D-高精氨酸或D-赖氨酸,其中由A,D,E和F表示的氨基酸是L-立体异构体; R1是低级烷基或烯丙基; R2是氢,低级烷基,炔丙基或烯丙基; R3是氢,低级烷基和烯丙基; R4是低级烷基,环烷基,杂芳基,未取代的芳基和被卤素,羟基或低级烷氧基取代的芳基; R5是-CH2CONH2,氨基烷基或胍基烷基; R6是-COOH或-CONH 2; 并且m为0或1,并且由*表示的不对称碳可以是D或L构型,具有特定的条件。